Avagacestat

Avagacestat

CAT N°: 16711
Price:

66.00 56.10

?-Secretase is a protease complex that cleaves single-pass transmembrane proteins, such as Notch receptors and ?-amyloid precursor protein (APP), within the transmembrane domain.{27051,25415} Avagacestat is a potent, orally bioavailable inhibitor of ?-secretase that more potently inhibits the cleavage of APP to A?40 than signaling through Notch (IC50s = 0.30 and 58 nM, respectively).{27425} It shows good pharmacokinetics in rats, dogs, and humans and passes the blood-brain barrier, reducing plasma, brain, and cerebrospinal fluid A?40 levels.{27425,27428} While suppressing the production of A?38, A?40, and A?42, ?-secretase inhibitors, including avagacestat, increase the level of APP ?-C-terminal fragment, both in vitro and in vivo, altering cell function.{27426} Avagacestat may impact Notch signaling in vivo, although it is generally considered a “Notch-sparing” ?-secretase inhibitor.{27427}

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View